SG3 Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Hold
0
125
2022
Q1
Hold
0
301
2021
Q4
Hold
0
338
2021
Q3
Hold
0
300
2021
Q2
Hold
0
326
2021
Q1
Hold
0
362
2020
Q4
Hold
0
304
2020
Q3
Hold
0
260